Nomura Holdings’s Inovio Pharmaceuticals INO Stock Holding History

Nomura Holdings’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$165K	Buy	+150,000	New	+$178K	﹤0.01%	1706
2025 Q3	–	Sell	-20,987	Closed	-$42.7K	–	1966
2025 Q2	$42.7K	Buy	20,987 +4,116	+24%	+$7.89K	﹤0.01%	1371
2025 Q1	$27.5K	Buy	+16,871	New	+$33.9K	﹤0.01%	1709
2015 Q1	–	Sell	-1,393	Closed	-$143K	–	2012
2014 Q4	$143K	Sell	1,393 -1,968	-59%	-$240K	﹤0.01%	2106
2014 Q3	$369K	Sell	3,361 -1,355	-29%	-$169K	﹤0.01%	2036
2014 Q2	$568K	Buy	4,716 +834	+21%	+$98.4K	﹤0.01%	1713
2014 Q1	$623K	Buy	3,882 +3,369	+657%	+$484K	﹤0.01%	1673
2013 Q4	$71K	Sell	513 -630	-55%	-$63K	﹤0.01%	1861
2013 Q3	$113K	Sell	1,143 -549	-32%	-$46K	﹤0.01%	2044
2013 Q2	$64K	Buy	+1,692	New	+$51.3K	﹤0.01%	2045

Other funds holding INO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Nomura Holdings's INO Position: Q2 2026 in Review

Nomura Holdings opened a new position in Inovio Pharmaceuticals (INO) in Q2 2026: 150,000 shares worth $165K. The stake represents ﹤0.01% of the portfolio and ranks #1706 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in INO as recently as Q2 2025.

Nomura Holdings first reported a position in INO in Q2 2013 and has held it in 10 quarters since. The position peaked at $623K in Q1 2014. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

Nomura Holdings held 150,000 shares of Inovio Pharmaceuticals worth $165K as of Q2 2026.
Inovio Pharmaceuticals was a new Nomura Holdings position in Q2 2026.
Inovio Pharmaceuticals made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1706 holding.
Nomura Holdings first reported a position in Inovio Pharmaceuticals in Q2 2013 and has held it in 10 quarters since.
Nomura Holdings's Inovio Pharmaceuticals position peaked at $623K in Q1 2014.
103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.